Arondel Equestrian Center - Blog #researchArondel Equestrian Center - Blog #researchhttps://www.arondelequestrian.com/blogs/tag/researchTue, 23 Dec 2025 17:52:15 -0800http://zoho.com/sites/<![CDATA[Equine Metabolic Syndrome: Understanding the Role of Ertugliflozin]]>https://www.arondelequestrian.com/blogs/post/equine-metabolic-syndrome-understanding-the-role-of-ertugliflozin1Recent studies have highlighted the potential benefits of using Ertugliflozin short-term in managing EMS.]]>

Equine Metabolic Syndrome: Understanding the Role of Ertugliflozin

Equine Metabolic Syndrome (EMS) is a complex endocrine disorder that affects horses, particularly those with a history of obesity, insulin resistance, and laminitis. Recent studies have highlighted the potential benefits of using Ertugliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, in managing EMS.

What is Ertugliflozin?

Ertugliflozin is a medication that works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine. This mechanism of action has been shown to improve insulin sensitivity and reduce glucose levels in horses with EMS.

Benefits of Ertugliflozin in EMS Management

Mechanism of Action

Benefits

Inhibits SGLT2, reducing glucose reabsorption in the kidneys

Improves insulin sensitivity, reduces glucose levels, and decreases insulin resistance

Increases glucose excretion in the urine

Reduces the risk of laminitis and other metabolic complications associated with EMS

Clinical Studies and Research

Several studies have investigated the efficacy and safety of Ertugliflozin in horses with EMS. A study published in the Journal of Equine Veterinary Science found that Ertugliflozin significantly improved insulin sensitivity and reduced glucose levels in horses with EMS.

Another study published in the Equine Veterinary Journal found that Ertugliflozin reduced the risk of laminitis and other metabolic complications associated with EMS in horses.

 Graph of horse Insulin reduction over time                  Average horse lameness score reduction 

graph of common side effect of ertugliflozin in horses

Conclusion

Ertugliflozin has shown promise as a potential short-term treatment for Equine Metabolic Syndrome.  However, further research is needed to fully understand its effects and potential side effects.

References


]]>Sun, 21 Sep 2025 10:21:45 -0400